Pre-activation of T lymphocytes by low dose of concanavalin A aggravates toll-like receptor-3 ligand-induced NK cell-mediated liver injury

International Immunopharmacology

Volumn 6, Issue 5, 2006, Pages 800-807

  Wang, Jing ^a   Sun, Rui ^a,b   Wei, Haiming ^a   Dong, Zhongjun ^a   Tian, Zhigang ^a,b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Concanavalin A; Hepatitis; Natural killer cells; Polyinosinic polycytidylic acid; T cells

Indexed keywords

AMINOTRANSFERASE; CONCANAVALIN A; GAMMA INTERFERON; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR 3;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEDIATED LYMPHOLYSIS; CONTROLLED STUDY; CYTOTOXICITY; DISEASE EXACERBATION; DRUG EFFECT; FEMALE; HEPATITIS; INTERFERON PRODUCTION; LIVER INJURY; LIVER NECROSIS; LIVER TOXICITY; LOW DRUG DOSE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION;

EID: 33645021541     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2005.11.023     Document Type: Article

References (40)

1. R. Manetti, F. Annunziato, L. Tomasevic, V. Gianno, P. Parronchi, and S. Romagnani Polyinosinic acid: polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon-α and interleukin-12 Eur J Immunol 25 1995 2656 2660
2. E. De Clercq Interferon induction by polynucleotides, modified polynucleotides, and polycarboxylates Methods Enzymol 78 1981 227 236
3. R.H. Wiltrout, A.M. Pilaro, M.E. Gruys, J.E. Talmadge, D.L. Longo, and J.R. Ortaldo Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow J Immunol 143 1989 372 378
4. P.M. Pitha, and J. Pitha Interferon induction by single-stranded polynucleotides modified with polybases J Gen Virol 24 1974 385 390
5. Y. Akiyama, G.W. Stevenson, E. Schlick, K. Matsushima, P.J. Miller, and H.C. Stevenson Differential ability of human blood monocyte subsets to release various cytokines J Leukoc Biol 37 1985 519 530
6. Z. Dong, H. Wei, R. Sun, Z. Hu, B. Gao, and Z. Tian Involvement of natural killer cells in Poly I:C-induced liver injury J Hepatol 41 2004 966 973
7. M. Ochi, H. Ohdan, H. Mitsuta, T. Onoe, D. Tokita, and H. Hara Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice Hepatology 39 2004 1321 1331
8. G. Tiegs, J. Hentschel, and A. Wendel A T cell-dependent experimental liver injury in mice inducible by concanavalin A J Clin Invest 90 1992 196 203
9. E. Jirillo, D. Caccavo, T. Magrone, E. Piccigallo, L. Amati, and A. Lembo The role of the liver in the response to LPS: experimental and clinical findings J Endotoxin Res 8 2002 319 327
10. Y. Kaneko, M. Harada, T. Kawano, M. Yamashita, Y. Shibata, and F. Gejyo Augmentation of Vα14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis J Exp Med 191 2000 105 114
11. K. Takeda, Y. Hayakawa, L. Van Kaer, H. Matsuda, H. Yagita, and K. Okumura Critical contribution of liver natural killer T cells to a murine model of hepatitis Proc Natl Acad Sci U S A 97 2000 5498 5503
12. S. Kusters, F. Gantner, G. Kunstle, and G. Tiegs Interferon γ plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A Gastroenterology 111 1996 462 471
13. C. Trautwein, T. Rakemann, D.A. Brenner, K. Streetz, L. Licato, and M.P. Manns Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice Gastroenterology 114 1998 1035 1045
14. H. Louis, A. Le Moine, E. Quertinmont, M.O. Peny, A. Geerts, and M. Goldman Repeated concanavalin A challenge in mice induces an interleukin 10-producing phenotype and liver fibrosis Hepatology 31 2000 381 390
15. T. Miyagi, T. Takehara, T. Tatsumi, T. Suzuki, M. Jinushi, and Y. Kanazawa Concanavalin A injection activates intrahepatic innate immune cells to provoke an antitumor effect in murine liver Hepatology 40 2004 1190 1196
16. N.C. Fernandez, A. Lozier, C. Flament, P. Ricciardi-Castagnoli, D. Bellet, and M. Suter Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo Nat Med 5 1999 405 411
17. M.T. Wilson, C. Johansson, D. Olivares-Villagomez, A.K. Singh, A.K. Stanic, and C.R. Wang The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion Proc Natl Acad Sci U S A 100 2003 10913 10918
18. J.A. Hobbs, S. Cho, T.J. Roberts, V. Sriram, J. Zhang, and M. Xu Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus J Virol 75 2001 10746 10754
19. M.C. Leite-de-Moraes, A. Herbelin, C. Gouarin, Y. Koezuka, E. Schneider, and M. Dy Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes J Immunol 165 2000 4367 4371
20. Q. Xiong, K. Hase, Y. Tezuka, T. Namba, and S. Kadota Acteoside inhibits apoptosis in d-galactosamine and lipopolysaccharide-induced liver injury Life Sci 65 1999 421 430
21. C. Galanos, M.A. Freudenberg, and W. Reutter Galactosamine-induced sensitization to the lethal effects of endotoxin Proc Natl Acad Sci U S A 76 1979 5939 5943
22. M.A. Freudenberg, D. Keppler, and C. Galanos Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin Infect Immun 51 1986 891 895
23. M. Leist, F. Gantner, S. Jilg, and A. Wendel Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release J Immunol 154 1995 1307 1316
24. J.G. Chosay, N.A. Essani, C.J. Dunn, and H. Jaeschke Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin-induced injury Am J Physiol 272 1997 G1195 G1200
25. M.B. Arvelo, J.T. Cooper, C. Longo, S. Daniel, S.T. Grey, and J. Mahiou A20 protects mice from d-galactosamine/lipopolysaccharide acute toxic lethal hepatitis Hepatology 35 2002 535 543
26. A. Mignon, N. Rouquet, M. Fabre, S. Martin, J.C. Pages, and J.F. Dhainaut LPS challenge in d-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock Am J Respir Crit Care Med 159 1999 1308 1315
27. I. Kurose, S. Miura, H. Higuchi, N. Watanabe, Y. Kamegaya, and M. Takaishi Increased nitric oxide synthase activity as a cause of mitochondrial dysfunction in rat hepatocytes: roles for tumor necrosis factor alpha Hepatology 24 1996 1185 1192
28. T.A. Fehniger, M.A. Cooper, G.J. Nuovo, M. Cella, F. Facchetti, and M. Colonna CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity Blood 101 2003 3052 3057
29. A. Moretta The dialogue between human natural killer cells and dendritic cells Curr Opin Immunol 17 2005 306 311
30. F. Gerosa, A. Gobbi, P. Zorzi, S. Burg, F. Briere, and G. Carra The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions J Immunol 174 2005 727 734
31. D.M. Andrews, C.E. Andoniou, A.A. Scalzo, S.L. van Dommelen, M.E. Wallace, and M.J. Smyth Cross-talk between dendritic cells and natural killer cells in viral infection Mol Immunol 42 2005 547 555
32. C. Borg, A. Jalil, D. Laderach, K. Maruyama, H. Wakasugi, and S. Charrier NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs Blood 104 2004 3267 3275
33. C. Carnaud, D. Lee, O. Donnars, S.H. Park, A. Beavis, and Y. Koezuka Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells J Immunol 163 1999 4647 4650
34. K.N. Schmidt, B. Leung, M. Kwong, K.A. Zarember, S. Satyal, and T.A. Navas APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA J Immunol 172 2004 138 143
35. M. Ramos-Casals, L.J. Jara, F. Medina, J. Rosas, J. Calvo-Alen, and J. Mana Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry]: patterns of clinical and immunological expression in 180 cases J Intern Med 257 2005 549 557
36. D. Sene, N. Limal, and P. Cacoub Hepatitis C virus-associated extrahepatic manifestations: a review Metab Brain Dis 19 2004 357 381
37. D. Olteanu, M. Argesanu, L. Radu, D. Nestor, S. Bratanescu, and D. Lupu Extrahepatic manifestations in hepatitis C virus infection Rom J Intern Med 42 2004 69 81
38. A. Mason Viral induction of type 2 diabetes and autoimmune liver disease J Nutr 131 2001 2805S 2808S
39. A. Palanduz, Y. Yildirmak, L. Telhan, M. Arapoglu, N. Urganci, and S. Tufekci Fulminant hepatic failure and autoimmune hemolytic anemia associated with Epstein-Barr virus infection J Infect 45 2002 96 98
40. J. Sevilla, M. del Carmen Escudero, R. Jimenez, M. Gonzalez-Vicent, J. Manzanares, and D. Garcia-Novo Severe systemic autoimmune disease associated with Epstein-Barr virus infection J Pediatr Hematol Oncol 26 2004 831 833